Covid 19

SNPsig® SARS-CoV-2 Real-Time PCR Mutation Detection/Allelic Discrimination Kits

  • An alternative to next generation sequencing and S gene target failure (SGTF), it enables scientists to analyze and monitor these specific genomic mutations. 

  • Pivotal in the role of screening for SARS-CoV-2 Variants for the purpose of genomic surveillance and studies.

Detection

Profile

  • Assay SNPsig® SARS-CoV-2 (20I/501Y.V1) detects 20I/501Y.V1 (UK).

  • Assay SNPsig® SARS-CoV-2 (20H/501Y.V2) detects 20H/501Y.V2 (SA).

  • Assay SNPsig® SARS-CoV-2 (N501Y) detects variants with the N501Y mutation (UK, SA and Brazil).

Important

Benefits

This assay offers the ability to track variants on-site and to generate a result in hours, compared to the current approach of next generation sequencing, which is typically constrained by limited capacity, cost and an offsite multi-day turnaround. This assay enables the identification of the non-variant virus and the UK, South Africa or Brazil variants, as well as any variant carrying the N501Y mutation.

KEY

Features

  • Can be used as reflex testing as only extracted RNA is needed.

  • Streamlined workflow for easy use with readily prepared master mix. 

  • Open platform compatibility.

  • No cold chain shipping. 

  • 96 reactions per pack, with master mix included.

  • This assay is one of the first commercially available for variant detection. 

Lab Experiment

What Can I Use With These Kits?

For Use With:

  • Sample Type - RNA extraction used for diagnosis

  • PCR Platform - Must be able to read fluorescence through the FAM and HEX channels

VIC_genesig_image2_Z-COVID-19.jpg

ADDITIONAL COVID-19 TESTING PRODUCTS

Drive-through Coronavirus Testing

Help

Follow Us

PO Box 307

Sewell, NJ 08080

©2021 by Victory Scientific. 

0
  • White LinkedIn Icon
  • YouTube
  • Twitter